Frankfurt - Delayed Quote • EUR
Cross Country Healthcare, Inc. (XXY.F)
At close: April 24 at 9:50 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,019,728.00
2,019,728.00
2,806,609.00
1,676,652.00
836,417.00
Cost of Revenue
1,569,318.00
1,569,318.00
2,178,923.00
1,301,653.00
633,685.00
Gross Profit
450,410.00
450,410.00
627,686.00
374,999.00
202,732.00
Operating Expense
318,738.00
318,738.00
337,511.00
226,212.00
186,480.00
Operating Income
131,672.00
131,672.00
290,175.00
148,787.00
16,252.00
Net Non Operating Interest Income Expense
-8,094.00
-8,094.00
-14,391.00
-6,866.00
-2,890.00
Other Income Expense
-20,684.00
-20,684.00
-19,459.00
-8,713.00
-25,692.00
Pretax Income
102,894.00
102,894.00
256,325.00
133,208.00
-12,330.00
Tax Provision
30,263.00
30,263.00
67,864.00
1,206.00
-188.00
Net Income Common Stockholders
72,631.00
72,631.00
188,461.00
132,002.00
-12,962.00
Diluted NI Available to Com Stockholders
72,631.00
72,631.00
188,461.00
132,002.00
-12,962.00
Basic EPS
2.07
--
5.09
3.60
-0.36
Diluted EPS
2.05
--
5.02
3.53
-0.36
Basic Average Shares
35,158.00
--
37,012.00
36,689.00
36,088.00
Diluted Average Shares
35,476.00
--
37,536.00
37,392.00
36,088.00
Total Operating Income as Reported
112,713.00
112,713.00
273,108.00
139,304.00
-9,160.00
Total Expenses
1,888,056.00
1,888,056.00
2,516,434.00
1,527,865.00
820,165.00
Net Income from Continuing & Discontinued Operation
72,631.00
72,631.00
188,461.00
132,002.00
-12,962.00
Normalized Income
87,232.49
87,232.49
203,745.33
141,399.15
12,068.82
Interest Expense
8,094.00
8,094.00
14,391.00
6,866.00
2,890.00
Net Interest Income
-8,094.00
-8,094.00
-14,391.00
-6,866.00
-2,890.00
EBIT
110,988.00
110,988.00
270,716.00
140,074.00
-9,440.00
EBITDA
129,335.00
129,335.00
283,292.00
149,926.00
3,231.00
Reconciled Cost of Revenue
1,569,318.00
1,569,318.00
2,178,923.00
1,301,653.00
633,685.00
Reconciled Depreciation
18,347.00
18,347.00
12,576.00
9,852.00
12,671.00
Net Income from Continuing Operation Net Minority Interest
72,631.00
72,631.00
188,461.00
132,002.00
-12,962.00
Total Unusual Items Excluding Goodwill
-20,682.00
-20,682.00
-20,795.00
-9,483.00
-25,412.00
Total Unusual Items
-20,682.00
-20,682.00
-20,795.00
-9,483.00
-25,412.00
Normalized EBITDA
150,017.00
150,017.00
304,087.00
159,409.00
28,643.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-6,080.51
-6,080.51
-5,510.68
-85.85
-381.18
12/31/2020 - 5/19/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EKH-R.BK Ekachai Medical Care Public Company Limited
7.60
+0.66%
PHG.BK Patrangsit Healthcare Group Public Company Limited
13.70
+1.48%
VIH.BK Srivichaivejvivat Public Company Limited
7.90
+0.64%
NTV.BK Nonthavej Hospital Public Company Limited
35.25
-0.70%
02M1.F Raffles Medical Group Ltd
0.6700
+0.75%
PIHLIS.HE Pihlajalinna Oyj
7.68
+0.26%
1419.HK Human Health Holdings Limited
1.000
0.00%
ONCO3.SA Oncoclínicas do Brasil Serviços Médicos S.A.
7.17
-1.24%